Clinical Trials Details

EA5142 ALCHEMIST- SUBSTUDY (Lung)

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)

Objective

A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers.

Clinical Trial Categories

  • Cancers and Other Neoplasms